Table 2 Baseline characteristics of patients taking one or two doses, and overall
One dose Population (N = 2139) | Two Dose Populationa | Overall Populationb (N = 3981) | ||
|---|---|---|---|---|
Rescue (N = 1549) | Recurrence (N = 97) | |||
Age, mean (SD), years | 41.1 (12.8) | 43.2 (11.8) | 43.5 (12.7) | 42.2 (12.4) |
Female | 84% | 84% | 88% | 84% |
BMI, mean (SD) | 30.4 (7.9) | 30.1 (9.5) | 31.3 (7.1) | 30.2 (8.6) |
Migraine history duration, mean (SD), years | 17.3 (12.6) | 20.4 (12.9) | 19.6 (13.3) | 18.7 (12.9) |
Migraine attacks/month in past 3 months, mean (SD) | 5.1 (1.7) | 5.4 (2.2) | 5.3 (1.7) | 5.2 (1.9) |
Patients with history of migraines with aura | 37% | 41% | 41% | 39% |
Patients using migraine reducing medications at randomizationc | 12% | 20% | 18% | 15% |